在子宫内膜癌中ROR1:与临床病理学特征,生存率和预后的相关性
1Department of Gynaecology, Shanxi Provincial People's Hospital, Taiyuan, China.
Biotechnology and applied biochemistry
|November 30, 2025
概括
受体氨酸激酶类孤儿受体1 (ROR1) 在子宫内膜癌 (EC) 中高度表达,与晚期和不良预后相关. 高ROR1表达预测了更短的生存期,特别是在早期的EC,这表明其作为生物标志物的潜力.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症生物标志物 癌症生物标志物
- 分子病理学分子病理学
背景情况:
- 在全球范围内,子宫内膜癌 (EC) 的发病率正在上升.
- 在EC中,受体氨酸激酶类孤儿受体1 (ROR1) 的作用尚不清楚.
- ROR1与各种癌症类型有关.
研究的目的:
- 调查ROR1表达在子宫内膜癌中的临床病理和预后意义.
- 评估ROR1作为EC进展和患者结果的潜在生物标志物.
主要方法:
- 免疫组织化学被用来分析66对EC和相邻的正常组织中的ROR1表达.
- 使用了统计分析,包括后勤回归和卡普兰-梅尔模型.
- 评估了ROR1表达和临床病理特征之间的关联,以及整体生存期 (OS).
主要成果:
- 与正常组织相比,ROR1在EC组织中显著过度表达 (65.15%与22.73%,p <0.05).
- 高ROR1表达与晚期临床阶段 (III-IV),II型组织学,淋巴结转移和不良预后相关 (p <0.05).
- 高ROR1表达预测了较短的生存期 (46个月与59个月,p < 0.001),并且是早期和I型EC的低生存率的独立预测因素.
结论:
- 在子宫内膜癌中,ROR1显著过度表达.
- 过度表达ROR1是晚期,II型组织学和EC中不良预后的独立预测因素.
- ROR1显示出作为预后生物标志物的潜力,用于预测子宫内膜癌的整体存活率,特别是在早期和I型疾病中.
关键词:
在ROR1中,ROR1是指ROR1.临床病理学特征 临床病理学特征宫内膜癌 (Endometrial Carcinoma) 是一个体内膜癌.免疫组织化学 免疫组织化学总体存活率 总体存活率预后 预后 预后更多相关视频
相关概念视频
01:03Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K
01:21Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K